Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis
Mary Barna Bridgeman1,2 1Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, USA; 2Department of Pharmacy, Robert Wood Johnson University Hospital, New Brunswick, NJ, USA Abstract: Patients suffering from a...
Saved in:
Main Author: | Bridgeman MB (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intranasal corticosteroid use in patients with allergic rhinitis
by: Svetlana V. Starostina, et al.
Published: (2021) -
Medication Adherence to Intranasal Corticosteroids in Allergic Rhinitis Patients with Comorbid Medical Conditions
by: Prempreet Kaur Manjit Singh, et al.
Published: (2022) -
Comparative efficacy and acceptability of licensed dose intranasal corticosteroids for moderate-to-severe allergic rhinitis: a systematic review and network meta-analysis
by: Kay Khine Soe, et al.
Published: (2023) -
Comparative study of the efficacy and safety of intranasal azelastine hydrochloride and fluticasone furoate in the treatment of allergic rhinitis
by: Nandish Chennakeshavaraju, et al.
Published: (2020) -
Allergic Rhinitis
Published: (2012)